A recent study found an association between COVID-19 infection and increased risk for various kinds of cancer caused by HPV.

Even though HPV positivity is a known factor in the diagnosis of cervical cancer, approximately 1 in 10 patients with cervical cancer test negative for HPV. A new study hypothesized a possible ...

Clinibase recently completed recruitment for an early-stage clinical trial now underway in Australia, to treat HPV.

Data shows Versamune® HPV may effectively treat HPV16-associated cancers; Phase 3 trial in head and neck cancer starts Q1 2025. PDS Biotechnology Corporation announced promising data for its lead ...

Cervical cancer is one of the most preventable cancers, although recent research suggests that the United States is backsliding in efforts to detect the disease early, when it is most curable. A new ...

Make no mistake about it: We're living in a time where there seems to be not much good news in sight, and women's health care—specifically with regard to cancer rates increasing among young women—is ...

Efficacy analysis of neoadjuvant PD-1 inhibitor combined with chemotherapy in various subanatomical sites of locally advanced and recurrent resectable head and neck squamous cell carcinoma: A ...

Key Points Interested in Corbus Pharmaceuticals Holdings, Inc.? Here are five stocks we like better. Corbus plans to start a ...

PDS Biotechnology Corporation has announced the publication of three abstracts related to its investigational immunotherapy, Versamune® HPV (PDS0101), which will be presented at the upcoming 2025 ...